The National Cancer Institute (NCI) is under fire for using federal funds to study ivermectin, a drug with no proven cancer-fighting properties. This decision comes after the drug was falsely promoted as a COVID-19 treatment. The research has sparked criticism, particularly given the lack of scientific evidence supporting ivermectin's efficacy against cancer and the millions of dollars funneled into the project.

Critics are questioning the NCI's priorities, especially since the study is based on anecdotal evidence and fringe theories. One of the sources for this study is Mel Gibson, who has claimed ivermectin cured stage 4 cancer in his friends. The NCI Director, Anthony Letai, seems to be trying to manage expectations while appeasing ivermectin proponents.

Ars Technica reported on the situation, highlighting concerns from NCI scientists who spoke anonymously, expressing dismay over the funding allocation. They see it as a waste of resources that could be used for more promising research. This research also raises questions about Letai's role, particularly in light of his dedication to the current administration.

Ultimately, the NCI's decision to study ivermectin for cancer treatment, despite the lack of scientific backing, is a controversial move. The situation spotlights the potential influence of fringe medical beliefs and the challenges of maintaining scientific integrity within the federal government. This study could be a waste of resources and potentially lead to false hope.